- Nonpeptide agonists of GLP 12013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Albiglutide - a GLP-1 agonist with a prolonged action2017 | First Faculty of Medicine, Third Faculty of Medicine
- Exenatide2008 | Second Faculty of Medicine
- Kardiovaskulární a renální účinky efpeglenatidu, agonisty receptoru pro GLP 1, jsou aditivní k účinkům inhibitorů SGLT22021 | First Faculty of Medicine
- How will diabetes treatment change with new pharmaceuticals?2015 | Second Faculty of Medicine
- Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-12011 | Third Faculty of Medicine, Second Faculty of Medicine
- Current treatment options for type 2 diabetes2008 | Second Faculty of Medicine
- Incretins in the treatment of type 2 diabetes2008 | Second Faculty of Medicine
- The effect of early initiation of liraglutide therapy – one year after. The improvement of long-term compensation and lipids level are comming2012 | First Faculty of Medicine
- Therapy based on the incretin effect2009 | Second Faculty of Medicine
- New possibilities in treatment of type 2 diabetes2012 | Second Faculty of Medicine
- Sitagliptin and metformin as an ideal combination for the treatment of type 2 diabetes2009 | Second Faculty of Medicine
- New antidiabetic drugs - availability of more effective treatment2017 | First Faculty of Medicine
- Nový bazální inzulinový analog degludek vstoupil do klinické praxe2019 | Faculty of Medicine in Hradec Králové
- Knowledge about GLP-1 based therapies changed the possibilities of diabetes treatment, but its use could be much broader2011 | Third Faculty of Medicine
- Tirzepatid - od diabetu k účinné léčbě obezity a významnému snížení kardiovaskulárních rizik2022 | First Faculty of Medicine
